Last updated 2026-07-20
Total raised
—
Stage
Mature
Founded
2013
Headcount
2
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences
About
Transseptal Solutions is a medical technology company dedicated to enhancing left atrial access procedures. They have developed the TSP Crosser™, an integrated transseptal system that includes a steerable sheath and a flexible needle with a radiopaque loop wire. This system is designed to facilitate reproducible and precise transseptal punctures, which are essential for various left-side heart treatments such as transcatheter mitral valve repair/replacement, PVL closure, atrial fibrillation ablation, and left-atrial appendage occlusion. The company aims to improve procedural efficiency, reduce complications, and serve the expanding indications of left heart treatment.
Headcount over time
From 2 (2018-11) to 2 (2025-02) · +0 (+0%) · 11 points · source: Finder history + radar grounding
Q&A
- What is Transseptal Solutions' primary focus?
- Transseptal Solutions is developing an integrated transseptal system, the TSP Crosser, designed to improve left-atrium-access procedures using a steerable sheath and a novel approach to transseptal puncture and left atrium navigation.
- When was Transseptal Solutions founded?
- Transseptal Solutions was founded in November 2013.
- What is the current employee count for Transseptal Solutions?
- Transseptal Solutions currently has 1-10 employees.
- Has Transseptal Solutions' product received regulatory approvals?
- Yes, Transseptal Solutions' TSP Crosser system is CE-marked and FDA-approved.
- What procedures can Transseptal Solutions' steerable sheath be used for?
- After puncture, the steerable sheath from Transseptal Solutions can serve as a guiding catheter for left-side procedures, including transcatheter mitral repair/replacement, PVL closure, atrial fibrillation ablation, and left-atrial appendage occlusion.
- Who are the key executives at Transseptal Solutions?
- The key executives at Transseptal Solutions include Elad Sapir as CEO and Eyal Teichman as CTO.
- What is Transseptal Solutions' primary sector classification?
- Transseptal Solutions is primarily classified under Health Tech & Life Sciences.
Team · 2
Francesco Maisano
Founder · Founder
Elad Sapir
Founder · CEO & Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
cardiologymedical-technologiesvalvessurgeonsmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | transseptalsolutions.com/ |
|---|---|
| linkedin.com/company/18601396 | |
| YouTube | youtube.com/channel/UChdunEYnlAGs6DT3r6TBvbg |
Identifiers & details
| Legal name | Transseptal Solutions Ltd. |
|---|---|
| Former names | TSP |
| Founded | 2013-11 |
| Employees (exact) | 2 |
Radar intelligence
Patents
| EPO | 9 |
|---|
Web history (Wayback)
| Domain | transseptalsolutions.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514039379 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2007-10-18 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2017 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | הירמוך 1 יבנה |